Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 73,602 | -109,781 | -325,991 | -227,313 | -124,014 |
| Depreciation Amortization | -7,054 | 2,194 | 8,746 | 7,722 | 6,269 |
| Accounts payable and accrued liabilities | 8,472 | 3,698 | 2,274 | 3,989 | 2,087 |
| Other Working Capital | -291,368 | 21,578 | -24,030 | -24,685 | -45,725 |
| Other Operating Activity | 44,377 | 23,509 | 94,285 | 68,234 | 46,376 |
| Operating Cash Flow | $-171,971 | $-58,802 | $-244,716 | $-172,053 | $-115,007 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8,636 | -2,786 | -17,833 | -12,984 | -6,934 |
| Purchase Of Investment | -901,841 | -523,714 | -1,115,040 | -628,330 | -505,460 |
| Sale Of Investment | 985,829 | 433,785 | 991,486 | 627,486 | 483,147 |
| Investing Cash Flow | $75,352 | $-92,715 | $-141,387 | $-13,828 | $-29,247 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,623 | 1,604 | 14,455 | 11,019 | 5,865 |
| Other Financing Activity | 0 | 0 | 296,215 | 0 | 0 |
| Financing Cash Flow | $10,623 | $1,604 | $310,670 | $11,019 | $5,865 |
| Beginning Cash Position | 219,544 | 219,544 | 294,977 | 294,977 | 294,977 |
| End Cash Position | 133,548 | 69,631 | 219,544 | 120,115 | 156,588 |
| Net Cash Flow | $-85,996 | $-149,913 | $-75,433 | $-174,862 | $-138,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | -171,971 | -58,802 | -244,716 | -172,053 | -115,007 |
| Capital Expenditure | -8,636 | -2,786 | -17,833 | -12,984 | -6,934 |
| Free Cash Flow | -180,607 | -61,588 | -262,549 | -185,037 | -121,941 |